Liu X - Search Results

1

A novel nanobody-based HER2-targeting antibody exhibits potent synergistic antitumor efficacy in trastuzumab-resistant cancer cells.

Liu X, Luan L, Liu X, Jiang D, Deng J, Xu J, Yuan Y, Xing J, Chen B, Xing D, Huang H. Liu X, et al. Front Immunol. 2023 Oct 25;14:1292839. doi: 10.3389/fimmu.2023.1292839. eCollection 2023. Front Immunol. 2023. PMID: 37954614 Free PMC article.

2

Targeting NAD+: is it a common strategy to delay heart aging?

Yuan Y, Liang B, Liu XL, Liu WJ, Huang BH, Yang SB, Gao YZ, Meng JS, Li MJ, Ye T, Wang CZ, Hu XK, Xing DM. Yuan Y, et al. Cell Death Discov. 2022 Apr 26;8(1):230. doi: 10.1038/s41420-022-01031-3. Cell Death Discov. 2022. PMID: 35474295 Free PMC article. Review.

3

Current and future perspectives for Helicobacter pylori treatment and management: From antibiotics to probiotics.

Liang B, Yuan Y, Peng XJ, Liu XL, Hu XK, Xing DM. Liang B, et al. Front Cell Infect Microbiol. 2022 Nov 25;12:1042070. doi: 10.3389/fcimb.2022.1042070. eCollection 2022. Front Cell Infect Microbiol. 2022. PMID: 36506013 Free PMC article. Review.

4

Corrigendum to "Advances in Trop2-targeted therapy: Novel agents and opportunities beyond breast cancer" [Pharmacology & Therapeutics 239 (2022) 108296].

Liu X, Deng J, Yuan Y, Chen W, Sun W, Wang Y, Huang H, Liang B, Ming T, Wen J, Huang B, Xing D. Liu X, et al. Pharmacol Ther. 2023 Mar;243:108336. doi: 10.1016/j.pharmthera.2022.108336. Epub 2023 Feb 15. Pharmacol Ther. 2023. PMID: 36804040 No abstract available.

5

Multi-material electrospinning: from methods to biomedical applications.

Xing J, Zhang M, Liu X, Wang C, Xu N, Xing D. Xing J, et al. Among authors: liu x. Mater Today Bio. 2023 Jun 23;21:100710. doi: 10.1016/j.mtbio.2023.100710. eCollection 2023 Aug. Mater Today Bio. 2023. PMID: 37545561 Free PMC article. Review.

6

Clinical advances in TNC delivery vectors and their conjugate agents.

Chen W, Wu Y, Wang J, Yu W, Shen X, Zhao K, Liang B, Hu X, Wang S, Jiang H, Liu X, Zhang M, Xing X, Wang C, Xing D. Chen W, et al. Among authors: liu x. Pharmacol Ther. 2024 Jan;253:108577. doi: 10.1016/j.pharmthera.2023.108577. Epub 2023 Dec 9. Pharmacol Ther. 2024. PMID: 38081519 Review.

7

The regulatory effect of growth differentiation factor 11 on different cells.

Shao Y, Liu T, Wen X, Zhang R, Liu X, Xing D. Shao Y, et al. Among authors: liu x, liu t. Front Immunol. 2023 Dec 8;14:1323670. doi: 10.3389/fimmu.2023.1323670. eCollection 2023. Front Immunol. 2023. PMID: 38143761 Free PMC article. Review.

8

The clinical development of antibody-drug conjugates for non-small cell lung cancer therapy.

Liu X, Deng J, Zhang R, Xing J, Wu Y, Chen W, Liang B, Xing D, Xu J, Zhang M. Liu X, et al. Front Immunol. 2023 Dec 11;14:1335252. doi: 10.3389/fimmu.2023.1335252. eCollection 2023. Front Immunol. 2023. PMID: 38162667 Free PMC article. Review.

9

Targeting Trop2 in solid tumors: a look into structures and novel epitopes.

Liu X, Li J, Deng J, Zhao J, Zhao G, Zhang T, Jiang H, Liang B, Xing D, Wang J. Liu X, et al. Front Immunol. 2023 Dec 20;14:1332489. doi: 10.3389/fimmu.2023.1332489. eCollection 2023. Front Immunol. 2023. PMID: 38179054 Free PMC article. Review.

10

Advanced function, design and application of skin substitutes for skin regeneration.

Zhang M, Xing J, Zhong Y, Zhang T, Liu X, Xing D. Zhang M, et al. Among authors: liu x. Mater Today Bio. 2023 Dec 20;24:100918. doi: 10.1016/j.mtbio.2023.100918. eCollection 2024 Feb. Mater Today Bio. 2023. PMID: 38223459 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

134,966 results

Search Page

Filters